• Dysbiosis Enhancing Linkage Towards Association with Canine Osteosarcoma (DEL-TACO)

    Currently Enrolling

    Intestinal dysbiosis has been associated with tumor progression of colorectal, lung, and breast cancer in human patients. To date, no studies have been published investigating the intestinal microbiome in dogs or humans with osteosarcoma (OSA). The objective of this study is to determine whether or not canine patients diagnosed with OSA have intestinal dysbiosis and if the presence of intestinal dysbiosis is associated with metastasis in these patients.

    Study Details
  • Survey of Endogenous Procalcitonin in Sepsis with Individual Sequencing (SEPSIS)

    Currently Enrolling

    The goal of this study is to evaluate changes in procalcitonin levels over time in canine patients surgically treated for sepsis secondary to an abdominal cause (i.e. ruptured intestine). Additional blood sample collection will also be performed to investigate for possible novel markers for sepsis using next generation sequencing for the future development of diagnostic test.

    Study Details
  • Validation of a Genomic Marker for Necrotizing Meningoencephalitis in Pugs

    Closed

    Single Day Clinic: March 7, 2020.

    Ethos Discovery is pursuing an investigation into the use of a novel therapy for NME in pugs. This study will only consist of a one-time visit for the blood sample collection. Participating pugs will get free wellness and neurological exams, general bloodwork, and NME-risk factor screening.

    Study Details
Loading